1/43
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
Acute Kidney Injury
Rapid loss of kidney function with or without decreased urine output
Can develop over hours or days
Potentially reversible but high mortality rate
AKI Assessments
H&P
ID cause
BUN
Creatinine
UA
Renal US/scan
CT
AKI Interventions
Treat cause
Fluid restrictions (strict ins/outs)
Low sodium/potassium diet
Low protein diet
Carefully monitor K+ levels
Calcium supplements or phosphate binding agents
Dialysis if necessary
AKI Teaching
Prevention and early recognition
High risk populations (elderly, blacks, hispanics, native americans, diabetes, HTN)
No nephrotoxic drugs
Prevent hypotension and hypovolemia
Contrast screening
Peritoneal Dialysis
Cath placed in abdomen using peritoneal cavity to act as filter
Patient able to move and walk around
Takes 3-5 hours during day or 5-8 hours at night
Dialysate solution should be clear, not cloudy
No machine required, using gravity
Watch for hernias & peritonitis
Signs of infection with Peritoneal Dialysis
Signs of infection around catheter site
Cloudy dialysate fluid
Fever
Hemodialysis
"artificial kidney"
Uses dialyzer machine
Machine cleans blood and then puts blood back into patient
Patients are typically on heparin or other forms of blood thinners
3-4 hours 3x/week
Hemodialysis Assessments
Assess sight
Palpate thrill at site
Hear the bruit
Check pulse and neurovascular assessments distal to the site
Assess for hypotension
Monitor K+
Hemodialysis Don'ts
Don't place BP cuff on that arm
Don't do blood draws from that arm
Hemodialysis Complications
⢠CVD
⢠Disequilibrium syndrome
⢠Exsanguination
⢠Hepatitis
⢠Hypotension
⢠Infection, including sepsis
⢠Muscle cramp
Peritoneal Dialysis Complications
⢠Abdominal pain
⢠Carbohydrate abnormalities
⢠Catheter outflow
⢠CVD
⢠Encapsulating sclerosing peritonitis
⢠Exit site infection
⢠Hernias
⢠Lipid abnormalities
⢠Lower back pain
⢠Peritonitis
⢠Protein loss
⢠Pulmonary problems
⢠Atelectasis
⢠Pneumonia
⢠Bronchitis
Dialysis NC
Check weight before and after
Strict ins/outs
Pulmonary fluid overload
Watch for s/s of infection
Muscle cramping
abdominal pain
Immunocompromised
CKD signs
GFR below 60
BUN & Creatinine
Protein
CKD Tx
HTN & Diabetes treatment (2 highest risk factors for CKD)
Fluid overload (strict ins/outs and daily weights)
Sodium restrictions
Fluid restriction
Potassium restriction
Protein restrictions
Urine albumin
Monitor BP and GFR
Med adherence
CKD Risk Factors
Age (over 60)
Cardiovascular disease
HTN
Diabetes
Ethnicity (blacks, native americans, hispanics)
Exposure to nephrotoxic drugs
Family Hx
Certain Autoimmune Disorders (Polycystic Kidney Disease, Goodpasture's Syndrome, SLE)
Chronic Kidney Disease Stage 1
GFR 90 or higher
Chronic Kidney Disease Stage 2
GFR 60-89
Mild
Kidney Injury Stage 3
GFR 30-50
Moderate
Chronic Kidney Disease Stage 4
below 59 = CKD
Severe
GFR 15-29
Chronic Kidney Disease Stage 5
GFR Less than 15 = kidney failure
Early stages of kidney disease
treat cause
prevent worsening and progression
Renal Failure s/s
Edema
Decreased urine output
Anemia
Heart Failure
CAD
Common Causes of AKI
Decreased Cardiac Output
Decreased Peripheral Vascular Resistance
Decreased Renovascular Blood Flow
Hypovolemia
Hemodialysis Fluid Restriction
Urine output plus 600
Peritoneal Dialysis Fluid Restriction
Unrestricted if weight and BP are controlled and if the patient has residual renal function
2 Leading Causes of CKD
HTN
Diabetes
Pre-ESRD Dietary Restrictions
Calcium: 1000-1500mg
Cals: 30-35 kcal/kg/day
Fluids as desired
Iron supplement recommended if patient is on EPO
Phosphate: 1-1.8g
Protein: 0.6-1 g/kg/day
Na+: 1-3g
Hemodialysis Dietary Restrictions
Cals: 30-35 kcal/kg/day
Fluids: Urine output plus 600
Iron supplement recommended if patient is on EPO
Phosphate: 0.6-1.2 g
K+: 2-4g
Protein: 1.2 g/kg/day
Na+: 2-3 g
Peritoneal dialysis Dietary Restrictions
Cals: 25-35 kcal/kg/day
Fluids: Unrestricted if weight and BP are controlled
Iron supplement recommended if patient is on EPO
Phosphate: 0.6-1.2 g
K+: unrestricted
Protein: 1.2-1.3 g/kg/day
Na+: 2-4 g
BPH Risk Factors
Age
Obesity
Lack of physical exercise
High red meat and animal fat intake
Alcohol use
Erectile Dysfunction
Smoking
Diabetes
Family Hx
BPH s/s
Gradual onset
Irritative symptoms
nocturia
frequency
dysuria, pain
incontinence
obstructive symptoms
Decrease in force of stream
Difficulty starting stream
Intermittency
Dribbling
BPH Diagnostics
H&P
DRE
UA
Culture and sensitivity
PSA
Serum creatinine
Postvoid residual by US
Renal US to evaluate for hydronephrosis
TRUS
Uroflowmetry
Cystoscopy
Urodynamic/pressure flow studies
BPH Management
Annual PSA and DRE
Repeat diagnostics if symptoms change
BPH Drug Therapy
5 alpha-reductase inhibitors (finasteride, dutasteride)
Alpha-adrenergic receptor blockers (Tamsulosin)
Combination
Erectogenic drugs (Tadalafil)
TURP
Gold standard of surgical treatment for BPH
Prostate Cancer Risk factors
Age
Ethnicity
Family Hx
Diet
Environment
Prostate Cancer
Slow growing
Many men live with it, some die, but most don't die from it
Prostate Cancer Diagnostics
H&P with DRE
PSA
TRUS or pelvic MRI
Whole body scan
CT of abdomen and pelvis with contrast
Prostate Cancer Management & Drug therapy
Same as BPH
Prostate Cancer Surgery
Radical prostatectomy
Cryotherapy
Orchiectomy
Prostate Cancer Radiation Therapy
External beam
Brachytherapy
Erectile Dysfunction
Inability to attain or maintain an erection that allows satisfactory sexual activity
50% of men 40-70 have ED to some degree
ED Risk Factors
Alcohol or drug induced
Endocrine
Genitourinary
Neurologic
Psychologic
Vascular
Aging
ED Management
Modify reversible causes
Drugs ("-Fil")
Vacuum Erection Device
Penile Implants
Intracavernosal self-injection
Intraurethral medication pellet